2018
DOI: 10.1177/1120672118771841
|View full text |Cite
|
Sign up to set email alerts
|

Outcome of trabeculectomy with Ologen versus Mitomycin C: A comparative prospective study in Bangladesh

Abstract: Trabeculectomy augmented with Ologen appeared to be as successful and safe as trabeculectomy augmented with Mitomycin C, with no reported adverse reaction to Ologen.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 20 publications
0
1
0
Order By: Relevance
“…MMC is an antimitotic agent widely used in trabeculectomy, inhibiting the postoperative fibrosis. Bleb leak was the most common complication,[ 37 38 39 40 41 42 ] followed by aqueous misdirection, corneal abrasion, and Tenon's cyst formation. Choroidal detachment, choroidal hemorrhage, and endophthalmitis were occasionally reported, but vision-threatening complication had ever been reported.…”
Section: Discussionmentioning
confidence: 99%
“…MMC is an antimitotic agent widely used in trabeculectomy, inhibiting the postoperative fibrosis. Bleb leak was the most common complication,[ 37 38 39 40 41 42 ] followed by aqueous misdirection, corneal abrasion, and Tenon's cyst formation. Choroidal detachment, choroidal hemorrhage, and endophthalmitis were occasionally reported, but vision-threatening complication had ever been reported.…”
Section: Discussionmentioning
confidence: 99%